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introduction: Participation in established cancer screening programs remains variable. 
Therefore, a renewed focus on how to increase screening uptake, including addressing 
structural barriers such as time, travel, and cost is needed. One approach could be the 
provision of combined cancer screening, where multiple screening tests are provided at 
the same time and location (essentially a ‘One Stop’ screening shop). This cohort study 
explored both cancer screening behavior and the acceptability of a combined screening 
approach.
Methods: Participants of the North Western Adelaide Health Study (NWAHS), South 
Australia were invited to participate in a questionnaire about cancer screening behaviors 
and the acceptability of a proposed ‘One Stop’ cancer screening shop. Data were 
collected from 10th August 2015 to 18th January 2016, weighted for selection proba-
bility, age, and sex and analyzed using descriptive and multivariable logistic regression 
analysis.
results: 1,562 people, 52% female (mean age 54.1  years  ±  15.2) participated. 
Reported screening participation was low, the highest being for Pap Smear (34.4%). 
Common reasons for screening participation were preventing sickness (56.1%, CI 
53.2–59.0%), maintaining health (51%, CI 48–53.9%), and free program provision 
(30.9%, CI 28.2–33.6%). Females were less likely to state that screening is not bene-
ficial [OR 0.37 (CI 0.21–0.66), p < 0.001] and to cite sickness prevention [OR 2.10 (CI 
1.46–3.00), p < 0.001] and free program [OR 1.75 (CI 1.22–2.51), p < 0.003] as reasons 
for screening participation. Of those who did not participate, 34.6% (CI 30.3–39.1%) 
stated that there was nothing that discouraged them from participation, with 55- to 
64-year olds [OR 0.24 (CI 0.07–0.74), p < 0.04] being less likely to cite this reason. 21% 
(CI 17.2–24.8%) thought they did not need screening, while a smaller proportion stated 
not having time (6.9%, CI 4.9–9.7%) and the costs associated with screening (5.2%, 
CI 3.5–7.7%). The majority of participants (85.3%, CI 81.9–88.2%) supported multiple 
screening being offered at the same time and location.
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conclusion: Identified screening behaviors in this study are similar to those reported in 
the literature. The high support for the concept of combined cancer screening demon-
strates that this type of approach is acceptable to potential end users and warrants 
further investigation.
Keywords: cancer screening, combined screening, screening behaviors, combined cancer screening, screening 
participation
Research Council, Australia) with written informed consent from 
all subjects. All subjects gave written informed consent in accord-
ance with the Declaration of Helsinki. The NWAHS protocol was 
approved by the Human Research Ethics Committees of the Queen 
Elizabeth and Lyell McEwin Hospitals (Adelaide, SA, Australia).
North Western Adelaide Health Study participants were 
invited to complete online or paper based questionnaires in rela-
tion to health issues and cancer screening, including; what type 
of screening the person was currently participating in, the benefit 
of screening, the enablers and barriers to screening participation 
and whether the participant would support the concept of dif-
ferent types of cancer screening being provided at the same time 
and location. If participants had not completed the questionnaire 
within 3 weeks, a reminder letter or e-mail was sent. Completion 
and return of the questionnaire was considered opting in and, 
therefore, consenting to study participation.
Data were collected from 10th August 2015 to 16th January 
2016. In phase 1 (1999–2003) of the NWAHS, data were weighted 
by region (western and northern health regions), age group, sex, 
and probability of selection in the household to the Australian 
Bureau of Statistics 1999 Estimated Resident Population (20) 
and 2001 Census data (21). This weighting was undertaken to 
reflect the population of interest and to correct for potential non-
response bias in which some groups of respondents may be over 
or underrepresented. For the current questionnaire study, data 
were weighted by sex, age group, and area of residence using 2011 
Australian Census data (22) and incorporated the original weight 
from Stage 1 in the calculation.
Data were analyzed using IBM Statistics SPSS version 24 (IBM, 
Armonk, New York, NY, USA) and STATA version 13 (StataCorp, 
College Station, TX, USA), including descriptive analysis and 
multivariable logistic regression analysis, with age, sex, marital 
status, education, annual gross income, and family structure 
included as covariates within the model and non-significant 
variables (p > 0.05) removed in a backwards stepwise elimination.
resUlTs
The total number of questionnaires posted or e-mailed was 2,895, 
with 7 participants subsequently being identified as deceased, 
leaving an eligible sample of 2,888. The number of completed 
questionnaires returned was 1,562 (54.1% response rate, 
Figure 1). Fifty two percent of respondents were female and 48% 
were male, with a mean age of 54.1 years (±15.2) and the major-
ity (77.2%) being of Australian birth origin. Table 1 presents the 
sociodemographic profile of the sample.
Despite the reported cancer screening participation rates being 
low (ranging from 3.5% for skin cancer screening up to 34.4% 
for Pap Smear; Table 2), 93.1% (CI 91.7–94.2%) of participants 
inTrODUcTiOn
Despite cancer being one of the leading causes of morbidity and 
mortality (1), current cancer screening participation rates are 
variable, both internationally (2, 3) and in Australia (4). This 
variability is of concern, as it has been demonstrated that par-
ticipating in organized cancer screening programs can identify 
cancer at an earlier stage, examples including bowel (5, 6), breast 
(7, 8), and cervical (9, 10), allowing for earlier detection and thus 
intervention in a person’s disease trajectory.
In the South Australian context, people currently have to 
schedule and find time to attend multiple appointments to 
achieve the recommended health and cancer screenings, with 
the clinics which offer these services being up to (depending 
upon location and mode of transport) 2 h away. In the broader, 
Australian context, in rural and remote regions, these services 
may not be able at all, necessitating long distance travel to the 
nearest biggest city to access the required services. These types 
of practical barriers to screening participation have also been 
well articulated in the literature, including time commitment, 
travel, administrative processes, and out-of-pocket costs (11–15). 
Given the aforementioned variability in screening participation, 
there is a need for a renewed focus on how these barriers can be 
circumvented to help improve cancer screening uptake.
Our team proposes that a potential solution to the problem 
of participation is the provision of a ‘One Stop’ combined health 
screening program, which, depending on age and gender would 
provide to people appropriate health and cancer screenings, 
inclusive of mammography, pap smear (women) prostate specific 
antigen screening (men), skin checks, and bowel cancer screening 
education at the same time and location. The overall objective 
of this program would be the earlier detection of factors that 
contribute to cancer and yet are amenable to intervention, such 
as smoking, alcohol consumption, and elevated body mass index 
(16) and identification of cancer at a potentially earlier stage.
However, before the implementation and evaluation of such a 
‘One Stop’ program, a gauge of the acceptability to the end user at 
the community level must be established (17, 18). Therefore, the 
aim of this study was to investigate in an adult population, current 
cancer screening participation, reasons for non/participation, the 
support for a (theoretical) ‘One Stop’ screening shop (different 
types of cancer screening provide at the same time and location) 
and the factors that may influence these outcomes.
MaTerials anD MeThODs
This study involved participants of the ongoing North Western 
Adelaide Health Study (NWAHS) (19), which has been carried out 
in accordance with the recommendations of the National Statement 
on Ethical Conduct in Human Research (National Health and 
FigUre 1 | Study numbers: eligible, non-responders, refusal, other, and total.
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thought that screening for cancer was beneficial (Table  3). 
Multivariable regression analysis demonstrated that females [OR 
0.37 (CI 0.21–0.66), p < 0.001] and adults living with a partner 
and no children [OR 0.42 (CI 0.20–0.91), p < 0.027] were less 
likely to state that screening is not beneficial.
The most commonly cited reasons for screening participation 
were preventing sickness (56.1%, CI 53.2–59.0%), maintaining 
health (51%, CI 48–53.9%), and free program provision (30.9%, 
CI 28.2–33.6%; Table 4). Females were more likely to cite sickness 
prevention [OR 2.10 (CI 1.46–3.00), p < 0.001], where as those 
aged 45–54 years [OR 0.45 (CI 0.23–0.90), p < 0.024] or >75 years 
[OR 0.46 (CI 0.24–0.91), p  <  0.025] and widows [OR 0.51 
(CI 0.34–0.78), p <  0.002] were less likely to choose “good for 
my health” as a reason for screening. The screening program 
being free was most likely to be cited by females [OR 1.75 (CI 
1.22–2.51), p < 0.003] and those aged 45–54 years [OR 2.55 (CI 
1.21–5.40), p < 0.014] and 55–64 years [OR 2.86 (CI 1.39–5.88), 
p < 0.004], respectively. Conversely, those on ≥$150,001 incomes 
were less likely to cite this as a reason [OR 0.26 (CI 0.10–0.65), 
p < 0.004].
Of those who did not currently participate in screening 
(n = 445), 34.6% (CI 30.3–39.1%) stated that there was nothing 
that discouraged them from participation, with 55 to 64 year 
olds [OR 0.24 (CI 0.07–0.74), p < 0.04] and related/unrelated 
adults living together [OR 4.18 (CI 1.11–15.78), p <  0.035] 
being the least likely to cite this reason. Twenty-one percent 
(CI 17.2–24.8%) of non-screening respondents thought they 
did not need screening, while a smaller proportion stated not 
having time (6.9%, CI 4.9–9.7%) and the costs associated with 
screening (5.2%, CI 3.5–7.7%) as reasons for non-participation 
(Table 5).
The acceptability of providing different types of cancer 
screenings on the same day at the same location (i.e., a ‘One Stop’ 
screening shop) was demonstrated, with the majority of partici-
pants (85.3%, CI 81.9–88.2%) stating they would support such a 
program (Table 6). Interestingly, those aged ≥75 years [OR 3.78 
(CI 1.67–8.57), p  <  0.001] and those earning an income of 
$60,001–$100,000 [OR 2.34 (CI 1.15–4.74), p  <  0.018] were 
more likely to state that they would not support or did not know 
whether they would support such a program. However, all other 
variables, such as sex, ages 30–74 years, all other income brackets, 
and family structure were not significant, demonstrating that a 
variety of people supported this concept.
DiscUssiOn
This study had an almost even representation of male and female 
participants (48 and 52%, respectively) with the mean age of 
54.1 years being within the current screening target population 
range. There was also a diversity of respondents in terms of 
educational level, marriage status, family structure, and income 
brackets. In terms of screening behavior, a number of outcomes 
in this study align with previous research, especially in relation 
to females being more engaged with screening. In general, it has 
been demonstrated that females use health services more than 
men (23), with a meta-analysis by Clark et al. also demonstrating 
that uptake of colorectal screening via fecal immunochemical 
testing was significantly greater in females in comparison to 
males, regardless of study design, screening organization or set-
ting (24).
The most common response as to why people participate 
in screening, that of preventing sickness and/or maintaining 
TaBle 5 | Factors that discourage respondents from participating in cancer 
screening (those that do not currently participate, only).
reasons for not screeninga n % 95% ci
Nothing discourages me 154 34.6 30.3–39.1
Do not think I need it 92 20.8 17.2–24.8
Do not have time 31 6.9 4.9–9.7
Cost 23 5.2 3.5–7.7
Location 13 3 1.8–5.0
Do not believe in it 1 0.1 b
Other reason 81 18.2 14.9–22.1
Not applicable 71 16 12.9–19.7
Do not know 61 13.7 10.8–17.2
Not stated 13 2.8 1.6–4.8
aParticipants could choose more than one answer.
bInsufficient numbers.
TaBle 4 | Reasons for participation in cancer screening (those that currently 
participate, only).
reasons for screeninga n % 95% ci
Helps to prevent me getting sick 626 56.1 53.2–59.0
It is good for my health 569 51 48.0–53.9
It is free 345 30.9 28.2–33.6
Family history of cancer 234 20.9 18.7–23.4
Other 88 7.9 6.4–9.6
Do not know 15 1.4 0.8–2.3
Not stated 32 2 1.4–2.9
aParticipants could choose more than one answer.
TaBle 3 | Proportion of respondents who thought that screening for cancer is 
beneficial.
response n % 95% ci
Yes 1,454 93.1 91.7–94.2
No 10 0.7 0.3–1.2 
Not stated 11 0.7 0.4–1.3
Do not know 87 5.6 4.5–6.8
Total 1,562 100
TaBle 2 | Proportion of respondents participating in cancer screening 
programs.
Type of screening n % 95% ci
PAP smear 538 34.4 32.1–36.8
Bowel cancer 532 34.1 31.7–36.4
Mammogram 449 28.7 26.5–31.0
Prostate cancer 272 17.4 15.6–19.4
Skin cancer 55 3.5 2.7–4.5
Other 14 0.9 0.5–1.5
None 445 28.5 26.3–30.8
Not stated 32 2 1.4–2.9
Total 1,562 100
TaBle 1 | Sociodemographic profile (n = 1,562).
Demographic n % 95% ci
age groups (years)
30–44 531 34 31.7–36.4
45–54 355 22.7 20.7–24.9
55–64 286 18.3 16.5–20.3
65–74 194 12.5 10.9–14.2
>75 194 12.4 10.9–14.2
country of birth
Australia 1,206 77.2 74.0–80.1
United Kingdom or Ireland 218 13.9 12.0–16.1
Europe, USSR, or Baltic States 83 5.3 3.8–7.4
Asia/other 54 3.5 2.1–5.7
Not stated 1 0.1 0.02–0.3
Marital status
Married 977 62.5 60.1–64.9
Widowed 140 9 7.6–10.5
Divorced 114 7.3 6.1–8.7
Separated 94 6 5.0–7.3
Never married 148 9.5 8.1–11.0
Not stated 44 2.8 2.1–3.8
highest education
Some primary school 7 0.4 0.2–0.9
Complete primary school 34 2.2 1.6–3.0
Some high school 370 23.7 21.7–25.9
Complete high school 225 14.4 12.7–16.2
Tafe/apprenticeship 82 5.3 4.3–6.5
Trade cert or diploma 400 25.6 23.5–27.8
Bachelor or higher 395 25.3 23.2–27.5
Other 7 0.5 0.2–0.9
Not stated 43 2.7 2.0–3.7
annual gross income ($)
12,001–20,000 26 1.6 1.1–2.4
20,001–40,000 126 8 6.8–9.5
40,001–60,000 219 14 12.4–15.8
60,001–80,000 205 13.1 11.5–14.9
80,001–100,000 158 10.1 8.7–11.7
100,001–150,000 233 14.9 13.2–16.7
150,001–200,000 243 15.6 13.8–17.4
>200,000 104 6.7 5.5–8.0
Not sure 54 3.4 2.6–4.5
Not stated 114 7.3 6.1–8.7
Family structure
Have children, living with both biological or adoptive 
parents
548 35.1 32.7–37.5
Step or blended family 65 4.2 3.3–5.3
Sole parent family 46 3 2.2–3.9
Shared care parenting 12 0.8 0.4–1.4
Adult living alone 249 15.9 14.2–17.8
Adult living with partner 422 27 24.9–29.3
Related adults living together 95 6.1 5.0–7.4
Related adults and children living together 19 1.2 0.8–1.9
Family/couples and unrelated adult/children living 
together
6 0.4 0.2–0.8
Unrelated adults living together 28 1.8 1.3–2.6
Other 12 0.7 0.4–1.3
Not stated 59 3.8 2.9–4.8
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health, can be considered as a motivator to screen, in terms 
of a form of self-care (25) or as a way of maintaining control 
over one’s health (26). In contrast to this, 20.8% of respondents 
that did not currently participate cited that they did not think 
they needed screening. From this particular study it is difficult 
to determine whether this is related to participants’ knowledge 
regarding screening and it is potential benefits, the individual’s 
own risk perception (of cancer) or a sense of ambivalence, which 
TaBle 6 | Proportion of respondents who would support different types of 
screening being offered on the same day at the same location.
response n % 95% ci
Yes 1,332 85.3 83.4–86.9
No 15 1 0.6–1.6 
Not stated 20 1.3 0.8–2.0
Do not know 195 12.5 10.9–14.2
Total 1,562 100
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has previously been shown to negatively influence screening 
uptake (25, 27).
It is interesting to note that in this study educational level had 
no significant impact upon whether respondents screened or not, 
nor did it have an impact on the reasons provided in relation to 
this. In addition, income level also had minimal influence. This 
is contrary to the established graded association between socio-
economic status (SES), for which education and income level are 
a significant component, and cancer screening participation 
(28). This association, namely the higher the SES the higher the 
participation rate with the opposite being true for low SES has 
been demonstrated in all cancer screening modalities, including 
bowel (29, 30), prostate (31, 32), cervical (33), and breast (34).
As it is recognized that certain sociodemographic character-
istics of individuals, such as sex, age, and ethnicity cannot be 
changed to improve health service use (35), attention must be 
directed to those factors that can be modified in relation to cancer 
screening utilization. As proposed in this study, one approach 
could be the provision of a combined health screening program 
(undertaken on the same day and at the same location). This type 
of program would target recognized structural barriers to screen-
ing, such as time, distance, and out-of-pocket costs, the reduction 
of which have been shown to facilitate access to and participation 
in organized cancer screening (11, 36).
However, who these strategies would most benefit is not 
entirely clear, as the review by Sabatino et al. (11) found that the 
evidence for reducing structural barriers to improve screening 
participation was stronger for breast and fecal occult blood test-
ing in comparison to cervical screening (35), while Brouwers 
et al. concurred that the evidence was strong for breast screening 
but also for cervical cancer and in contrast to the Sabatino et al. 
(11) review, not for colorectal cancer screening (37). Despite 
these uncertainties, what is known is that there are synergies that 
can be potentially harnessed with the provision of an organized, 
integrated service such as the ‘One Stop’ screening shop.
In particular, it has been demonstrated that the decision to 
participate in one form of cancer screening or periodic health 
assessment can positively influence the decision to participate in 
other forms of cancer screening, including breast and cervical 
(38, 39) and the completion of colorectal, prostate (PSA) and 
mammography screening (40). A decision made potentially 
easier if screening services were available to the person on the 
same day and at the same location.
The acceptability and satisfaction of the end user to programs 
that combine two or more assessments and/or screening tests 
at the same time has been previously demonstrated, including 
the provision of multiple health tests on the same day to rural 
men (41) a community health day that provided education and 
basic cancer screening tests to underserved Hawaiians (42) and 
combined colon and endometrial cancer screening for women 
with Lynch syndrome (43). The consistently high acceptability 
and satisfaction in relation to combined testing approaches is 
also mirrored in this study, with 85.3% of respondents stating 
they would support a combined cancer screening program. 
However, this is the first study to demonstrate the potential 
acceptability of combined cancer screening being provided at 
the same time and location and demonstrates that this type 
of approach is a potentially viable and acceptable option 
for circumventing some of the known barriers to screening 
participation.
limitations
The predominantly Australian respondents, with a small number 
from different culturally and linguistically diverse backgrounds 
makes it likely that these groups are underrepresented in the study 
outcomes. This limitation is somewhat mitigated by the large 
sample size of this study and the other diverse sociodemographic 
backgrounds (in terms of age, family structure and income, and 
educational level) of respondents.
In addition, participants’ access/distance to health and cancer 
screening services was not specifically measured in this study. 
However, given the current context of participants having to 
attend multiple screening appointments at different times and 
locations (which inherently involves traveling), one could assume 
that the majority (85.3%) found the concept of a ‘One Stop’ shop 
a more appealing option.
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